If you're looking for MS care in Texas, you have access to 21 treatment centers across the state, including major programs like Baylor College of Medicine Multiple Sclerosis Center and UTSouthwestern Medical Center of Dallas. Use this page to compare centers in regions such as Houston, San Antonio and Dallas so you can find the team and services that fit your needs.
21 MS treatment centers32 active clinical trials3 providers with Medicare prescribing dataTop centers in Houston, San Antonio and Dallas
Center types in Texas
Regional Neurology Group (9)
Academic MS Center (8)
Community Hospital Program (2)
Boutique MS Practice (1)
Dedicated MS Practice (1)
Filter by type:
43% of MS centers in Texas are classified as Regional Neurology Group facilities.
Centers with Most Active Trials in Texas
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
MS Care by City
Active MS clinical trials in Texas
See all 44 MS trials in Texas →ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Houston · Katy · +3
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Dallas · El Paso · +5
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Dallas · San Antonio · +1
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Houston · Sherman
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Dallas · Plano
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
El Paso · Lubbock · +3
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Dallas · Fort Worth · +3
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Dallas · Frisco · +2

















